Key result
Tocilizumab resolves symptoms and pericardial effusion within 3 weeks in a case of RA-associated pericarditis.
Why the study?
Does tocilizumab improve pericarditis associated with rheumatoid arthritis?
Population
1 male patient, age 73 years, with rheumatoid arthritis, chronic renal failure, organizing pneumonia, and…
Design
Case_report
Follow-up
about 3 weeks
Authors
Loading...
May warrant consideration in refractory RA pericarditis; hypothesis-generating and requires prospective trials before practice change.
Case Report (n=1)
Does tocilizumab improve pericarditis associated with rheumatoid arthritis?
Tocilizumab administration appears worthwhile in RA patients with vasculitis-associated pericarditis who do not respond to conventional treatment.
Yoshida et al. (2014) conducted a case report in Rheumatoid arthritis complicated by pericarditis (n=1). Tocilizumab was evaluated on Resolution of pericardial effusion and symptoms. Tocilizumab administration (8 mg/kg) successfully resolved symptoms and pericardial effusion within 3 weeks in a 73-year-old male with rheumatoid arthritis-associated pericarditis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: